Clinical Trials
3 trialsNCT00492050 2026-03-11
Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01436968 2025-07-30
PrTK03
Candel Therapeutics, Inc.
Phase 3 Active not recruiting
NCT02768363 2025-07-30
Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Candel Therapeutics, Inc.
Phase 2 Active not recruiting